Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|December 11, 2024
Increase in prevalence and costs of cirrhosis in the Netherlands: a nationwide hospital diagnosis data analysisKoos de Wit, Diederick J van Doorn, Gwen M C Masclee, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2023
The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular ComplicationsIulia Minciuna, Caroline den Hoed, Adriaan J van der Meer, et al.Journal of Hepatology|August 29, 2017
Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosisSuraj A Sharma, Matthew Kowgier, Bettina E Hansen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.Journal of Gastroenterology and Hepatology|February 17, 2015
Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosisRaoel Maan, Adriaan J van der Meer, Bettina E Hansen, et al.Journal of Hepatology|May 1, 2014
Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosisRaoel Maan, Adriaan J van der Meer, Bettina E Hansen, et al.Journal of Hepatology|November 26, 2020
Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severityLisette A P Krassenburg, Raoel Maan, Alnoor Ramji, et al.Journal of Gastroenterology and Hepatology|December 10, 2015
Improvement of platelets after SVR among patients with chronic HCV infection and advanced hepatic fibrosisAdriaan J van der Meer, Raoel Maan, Bart J Veldt, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and CirrhosisRaoel Maan, Marjolein van Tilborg, Katja Deterding, et al.Antiviral Research|September 15, 2014
Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patientsMeike H van der Ree, Adriaan J van der Meer, Joep de Bruijne, et al.Pageof 4